What are the most important cutaneous vasculitides?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Important Cutaneous Vasculitides

The most important cutaneous vasculitides to recognize are cutaneous leukocytoclastic angiitis (the most common form in adults), IgA vasculitis/Henoch-Schönlein purpura (most common in children), and the ANCA-associated vasculitides (Wegener granulomatosis/GPA, microscopic polyangiitis, Churg-Strauss syndrome/EGPA) which carry significant morbidity and mortality risk. 1, 2

Classification by Clinical Importance

Small Vessel Vasculitides (Highest Frequency)

Cutaneous Leukocytoclastic Angiitis (CLA)

  • Most common cutaneous vasculitis in adults 1
  • Presents as palpable purpura on lower extremities - this is nearly pathognomonic 3
  • Up to 50% remain etiologically unexplained despite thorough workup 1
  • Usually self-limited and resolves spontaneously 1
  • Critical distinction: Can be isolated cutaneous disease OR herald systemic involvement

IgA Vasculitis (Henoch-Schönlein Purpura)

  • Most common vasculitis in children 1
  • Distinguished by IgA deposition on direct immunofluorescence - this is diagnostically crucial 4, 5
  • Skin involvement often predominates even when systemic 2
  • Can affect kidneys and GI tract with significant morbidity

ANCA-Associated Vasculitides (Highest Mortality Risk)

Granulomatosis with Polyangiitis (Wegener), Microscopic Polyangiitis, Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 6

  • These require aggressive immunosuppression with corticosteroids plus cyclophosphamide due to high risk of permanent organ damage or death 4
  • Cutaneous manifestations include palpable purpura PLUS nodules or livedo - this combination suggests ANCA-associated disease rather than simple immune complex vasculitis 3
  • Coexistence of pan-dermal small-vessel and subcutaneous muscular-vessel vasculitis indicates ANCA-associated disease 4

Medium Vessel Vasculitides

Polyarteritis Nodosa (PAN) 6

  • Systemic PAN: multiple manifestations including digital infarction, livedo racemosa, subcutaneous nodules 3
  • Cutaneous PAN: predominantly subcutaneous nodules surrounded by livedo racemosa on lower legs 3
  • Important because cutaneous form has better prognosis than systemic

Key Diagnostic Features That Determine Importance

Red Flags for Systemic Disease (High Morbidity/Mortality)

  • Constitutional symptoms: weight loss, fever, exhaustion 1
  • Ulcerative or necrotic lesions 7
  • Hematuria (renal involvement) 7
  • GI complaints 7
  • Nodules or livedo in addition to purpura 3, 4

Histopathological Priorities

Obtain two biopsies when immune complex vasculitis suspected 5:

  1. For DIF: Early, partially blanchable macule - the type of perivascular immunoglobulin (IgA vs IgG/IgM) has prognostic significance 4, 5
  2. For routine histology: Most tender, reddish or purpuric lesion extending to subcutis 4

Serial sections often required to identify main vasculitic lesion 4

Clinical Pitfalls

Do not confuse vasculitis with vasculopathy (pseudovasculitis) 1, 4:

  • Thrombotic disorders like antiphospholipid syndrome can mimic vasculitis clinically
  • These require anticoagulation, NOT immunosuppression
  • Histopathology distinguishes true vessel wall inflammation from thrombotic occlusion

Location matters for differential diagnosis 3:

  • Lower extremity palpable purpura = immune complex small vessel vasculitis
  • Cold-exposed area necrosis = consider cryoglobulinemic vasculitis
  • Nailfold involvement = consider lupus or rheumatoid-associated vasculitis
  • Extensor surface plaques = erythema elevatum diutinum

Secondary Causes Requiring Different Management

Vasculitis triggered by 1, 2:

  • Infections: Treat underlying infection
  • Drugs: Discontinue offending agent
  • Connective tissue diseases: Treat underlying CTD
  • Malignancies: Address underlying cancer

The extent of diagnostic workup should be proportional to severity, duration, systemic symptoms, and recurrence 5 - not a blanket approach for all patients.

References

Research

[Cutaneous Vasculitides - Clinical Manifestations, Diagnosis, and Aetiology].

Therapeutische Umschau. Revue therapeutique, 2022

Research

[Cutaneous symptoms of various vasculitides].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2015

Research

Clinical approach to cutaneous vasculitis.

American journal of clinical dermatology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.